tiprankstipranks
Advertisement
Advertisement

ONC Stock Latest News

BeOne Medicines Advances BGB-58067 With Key Drug-Interaction Study in Healthy Volunteers
Company AnnouncementsBeOne Medicines Advances BGB-58067 With Key Drug-Interaction Study in Healthy Volunteers
9m ago
ONC
BeOne Medicines announces presentation of Phase 3 data in CLL patients
PremiumThe Fly
BeOne Medicines announces presentation of Phase 3 data in CLL patients
6d ago
ONC
BeOne Medicines Advances CDK4 Cancer Drug With Completion of Key Phase 1 Trial
PremiumCompany Announcements
BeOne Medicines Advances CDK4 Cancer Drug With Completion of Key Phase 1 Trial
7d ago
ONC
BeOne Medicines Completes First-in-Human Study of New B7H3 Cancer Drug
PremiumCompany Announcements
BeOne Medicines Completes First-in-Human Study of New B7H3 Cancer Drug
9d ago
ONC
AI Models Turn Cautious on BeOne Medicines (ONC) as Valuation and Technicals Weigh
PremiumAI Analyst Ratings
AI Models Turn Cautious on BeOne Medicines (ONC) as Valuation and Technicals Weigh
12d ago
ONC
BeOne Medicines Halts Early KRAS Trial, Resetting Expectations in a Crowded Oncology Race
PremiumCompany AnnouncementsBeOne Medicines Halts Early KRAS Trial, Resetting Expectations in a Crowded Oncology Race
14d ago
ONC
Zymeworks and BeOne: Long‑Term Cancer Study Update Supports Durable Drug Story
Premium
Company Announcements
Zymeworks and BeOne: Long‑Term Cancer Study Update Supports Durable Drug Story
14d ago
ONC
ZYME
BeOne Medicines price target raised to $436 from $425 at RBC Capital
Premium
The Fly
BeOne Medicines price target raised to $436 from $425 at RBC Capital
15d ago
ONC
New Combo Trial in Esophageal Cancer: What LBL-007’s Phase 2 Update Means for ONC Investors
PremiumCompany Announcements
New Combo Trial in Esophageal Cancer: What LBL-007’s Phase 2 Update Means for ONC Investors
20d ago
ONC
BeOne Medicines’ combination shows improved survival in adenocarcinoma
PremiumThe Fly
BeOne Medicines’ combination shows improved survival in adenocarcinoma
21d ago
ONC
BeOne Medicines Advances First-in-Human Solid Tumor Trial With BG-C0979
PremiumCompany Announcements
BeOne Medicines Advances First-in-Human Solid Tumor Trial With BG-C0979
21d ago
ONC
BeOne Medicines Pits New Breast Cancer Drug Against CDK4/6 Leaders in Phase 3 Test
PremiumCompany Announcements
BeOne Medicines Pits New Breast Cancer Drug Against CDK4/6 Leaders in Phase 3 Test
26d ago
ONC
BeOne Medicines Halts Early Lung Cancer Trial, Resetting Expectations for EGFR Pipeline
PremiumCompany AnnouncementsBeOne Medicines Halts Early Lung Cancer Trial, Resetting Expectations for EGFR Pipeline
26d ago
ONC
BeOne Wins FDA Nod for BEQALZI Lymphoma Therapy
Premium
Company Announcements
BeOne Wins FDA Nod for BEQALZI Lymphoma Therapy
1M ago
8K
ONC
BeOne Medicines price target raised to $367 from $364 at Leerink
Premium
The Fly
BeOne Medicines price target raised to $367 from $364 at Leerink
1M ago
ONC
BeOne Medicines’ Beqalzi granted accelerated approval by FDA
PremiumThe Fly
BeOne Medicines’ Beqalzi granted accelerated approval by FDA
1M ago
ONC
BeOne Medicines price target raised to $395 from $389 at Morgan Stanley
PremiumThe Fly
BeOne Medicines price target raised to $395 from $389 at Morgan Stanley
1M ago
ONC
BeOne Medicines price target raised to $409 from $405 at Barclays
PremiumThe Fly
BeOne Medicines price target raised to $409 from $405 at Barclays
1M ago
ONC
BeOne Medicines price target raised to $420 from $410 at Guggenheim
PremiumThe Fly
BeOne Medicines price target raised to $420 from $410 at Guggenheim
1M ago
ONC
BeOne Medicines reports Q1 adjusted EPS $3.24 vs. $1.22 last year
PremiumThe FlyBeOne Medicines reports Q1 adjusted EPS $3.24 vs. $1.22 last year
1M ago
ONC
BeOne Medicines raises FY26 revenue view to $6.3B-$6.5B from $6.2B-$6.4B
Premium
The Fly
BeOne Medicines raises FY26 revenue view to $6.3B-$6.5B from $6.2B-$6.4B
1M ago
ONC
AMD downgraded, Airbnb upgraded: Wall Street’s top analyst calls
Premium
The Fly
AMD downgraded, Airbnb upgraded: Wall Street’s top analyst calls
1M ago
AMD
BDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >